Share 'Prosensa and GlaxoSmithKline initiate development of four additional products under existing alliance in Duchenne Muscular Dystrophy.'
http://www.prosensa.eu/press-room/press-releases/2010-06-23-Prosensa-and-GlaxoSmithKline-initiate-development-of-four-additional-products-under-existing-alliance-in-DMD.php Leiden, June 23, 2010 – Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, announces the initiation of two further programmes under its existing alliance with GSK covering novel RNA-base…
You can share this discussion in two ways…
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
